Largest pharmaceutical companies by net assets
Shareholders' equity at the end of the latest fiscal year: what the company owns less what it owes. A negative figure means it owes more than it owns.
Pfizer leads the 61 pharmaceutical companies ranked by net assets, at AED 317.6B, ahead of Johnson & Johnson (AED 299.5B) and Sanofi (AED 290.9B). Figures as of 18 Nov 2026, 17:47 UTC, from Yahoo Finance quotes.
Key facts
- Companies ranked
- 61
- First
- PfizerAED 317.6B
- Median
- AED 3.2B
- Combined market value
- AED 18.69T
- Countries
- 10
Market values as of .
All countries▾
All sectors▾
Pharmaceuticals▾
| # | Company | Net assets ↓ | Market cap | Price | Today | 1 year | Price, 30 days | Country |
|---|---|---|---|---|---|---|---|---|
| 1 | PfizerPFE · Health Care | AED 317.6B | AED 589.6B | AED 103.44 | 1.07% down | 14% up | ||
| 2 | Johnson & JohnsonJNJ · Health Care | AED 299.5B | AED 2.44T | AED 1,014.06 | 0.93% down | 38% up | ||
| 3 | SanofiSNY · Health Care | AED 290.9B | AED 417.4B | AED 173.82 | 0.43% down | 4% down | ||
| 4 | Merck & CoMRK · Health Care | AED 193.2B | AED 1.26T | AED 509.88 | 3.17% down | 51% up | ||
| 5 | Abbott LaboratoriesABT · Health Care | AED 191.5B | AED 665.4B | AED 384.17 | 0.11% down | 17% down | ||
| 6 | AstraZenecaAZN · Health Care | AED 178.7B | AED 1.02T | AED 659.12 | 1.54% down | 2% up | ||
| 7 | Takeda PharmaceuticalTAK · Health Care | AED 170.9B | AED 251.1B | AED 78.60 | 1.11% down | 54% up | ||
| 8 | NovartisNVS · Health Care | AED 169.4B | AED 1.08T | AED 572.96 | 1.97% down | 25% up | ||
| 9 | Regeneron PharmaceuticalsREGN · Health Care | AED 114.8B | AED 360.7B | AED 3,486.37 | 0.89% down | 36% up | ||
| 10 | Novo NordiskNVO · Health Care | AED 105.8B | AED 640.9B | AED 145.41 | 2.73% down | 17% down | ||
| 11 | Eli LillyLLY · Health Care | AED 97.5B | AED 4.55T | AED 5,107.21 | 1.77% down | 35% up | ||
| 12 | GSKGSK · Health Care | AED 79.8B | AED 359.2B | AED 179.20 | 0.91% down | 6% up | ||
| 13 | Vertex PharmaceuticalsVRTX · Health Care | AED 68.6B | AED 499.5B | AED 1,970.22 | 0.42% up | 27% up | ||
| 14 | Bristol-Myers SquibbBMY · Health Care | AED 67.8B | AED 450.4B | AED 220.33 | 2.22% down | 34% up | ||
| 15 | ViatrisVTRS · Health Care | AED 54B | AED 87.4B | AED 76.19 | 1.44% up | 96% up | ||
| 16 | Royalty PharmaRPRX · Health Care | AED 35.7B | AED 146.4B | AED 254.56 | 0.92% up | 78% up | ||
| 17 | Teva Pharmaceutical IndustriesTEVA · Health Care | AED 29.1B | AED 181.2B | AED 155.30 | 0.79% down | 74% up | ||
| 18 | United TherapeuticsUTHR · Health Care | AED 26.1B | AED 90.9B | AED 2,133.93 | 0.53% down | 23% up | ||
| 19 | Elanco Animal HealthELAN · Health Care | AED 24B | AED 49.2B | AED 98.50 | 3.75% up | 20% up | ||
| 20 | BioMarin PharmaceuticalBMRN · Health Care | AED 22.4B | AED 43.1B | AED 222.74 | 3.65% up | 11% up | ||
| 21 | GrifolsGRFS · Health Care | AED 21.5B | AED 21.2B | AED 31.11 | 1.85% down | 1% up | ||
| 22 | GenmabGMAB · Health Care | AED 21.5B | AED 116.6B | AED 189.15 | 0.89% down | 70% up | ||
| 23 | Roivant SciencesROIV · Health Care | AED 16.6B | AED 102.9B | AED 142.08 | 0.06% down | 90% up | ||
| 24 | BeOne MedicinesONC · Health Care | AED 16B | AED 170.2B | AED 1,489.83 | 1.84% down | 17% up | ||
| 25 | Jazz PharmaceuticalsJAZZ · Health Care | AED 15.9B | AED 58.1B | AED 905.18 | 2.39% up | 37% up | ||
| 26 | Dr. Reddy's LaboratoriesRDY · Health Care | AED 14.7B | AED 46B | AED 55.15 | 1.52% up | 5% up | ||
| 27 | ZoetisZTS · Health Care | AED 12.2B | AED 126.5B | AED 311.45 | 1.58% up | 29% down | ||
| 28 | AlkermesALKS · Health Care | AED 6.7B | AED 28.9B | AED 172.11 | 3.10% up | 58% up | ||
| 29 | Ligand PharmaceuticalsLGND · Health Care | AED 3.7B | AED 22.1B | AED 1,104.45 | 2.35% up | 43% up | ||
| 30 | Legend BiotechLEGN · Health Care | AED 3.7B | AED 11.6B | AED 59.57 | 0.68% up | 42% down | ||
| 31 | Praxis Precision MedicinesPRAX · Health Care | AED 3.2B | AED 31.7B | AED 1,133.26 | 1.15% up | 61% up | ||
| 32 | Alnylam PharmaceuticalsALNY · Health Care | AED 2.9B | AED 74.8B | AED 558.78 | 2.79% down | 66% down | ||
| 33 | Belite BioBLTE · Health Care | AED 2.8B | AED 23.6B | AED 581.88 | 0.45% up | 31% up | ||
| 34 | InsmedINSM · Health Care | AED 2.7B | AED 97.5B | AED 444.43 | 0.70% down | 40% down | ||
| 35 | Spyre TherapeuticsSYRE · Health Care | AED 2.6B | AED 34B | AED 357.75 | 3.83% up | 286% up | ||
| 36 | Summit TherapeuticsSMMT · Health Care | AED 2.4B | AED 31.4B | AED 39.21 | 0.05% up | 36% down | ||
| 37 | TG TherapeuticsTGTX · Health Care | AED 2.4B | AED 36.8B | AED 243.32 | 5.65% up | 107% up | ||
| 38 | Corcept TherapeuticsCORT · Health Care | AED 2.4B | AED 27.5B | AED 251.05 | 2.45% down | 8% down | ||
| 39 | Cogent BiosciencesCOGT · Health Care | AED 2.3B | AED 18.1B | AED 103.87 | 1.54% up | 20% down | ||
| 40 | Protagonist TherapeuticsPTGX · Health Care | AED 2.3B | AED 30.1B | AED 460.64 | 0.60% up | 46% up | ||
| 41 | Madrigal PharmaceuticalsMDGL · Health Care | AED 2.2B | AED 34.7B | AED 1,493.25 | 3.65% down | 24% down | ||
| 42 | Kiniksa Pharmaceuticals InternationalKNSA · Health Care | AED 2.1B | AED 27.6B | AED 350.84 | 0.44% up | 126% up | ||
| 43 | Edgewise TherapeuticsEWTX · Health Care | AED 1.9B | AED 16.8B | AED 153.78 | 0.40% down | 88% up | ||
| 44 | ABIVAXABVX · Health Care | AED 1.9B | AED 27B | AED 308.59 | 2.34% up | 27% down | ||
| 45 | Dianthus TherapeuticsDNTH · Health Care | AED 1.8B | AED 18B | AED 320.45 | 0.31% up | 113% up | ||
| 46 | Ionis PharmaceuticalsIONS · Health Care | AED 1.8B | AED 16.9B | AED 101.33 | 2.34% up | 64% down | ||
| 47 | Oruka TherapeuticsORKA · Health Care | AED 1.7B | AED 24.4B | AED 359.92 | 1.74% up | 241% up | ||
| 48 | Arrowhead PharmaceuticalsARWR · Health Care | AED 1.7B | AED 22.6B | AED 159.95 | 1.30% up | 10% up | ||
| 49 | Definium TherapeuticsDFTX · Health Care | AED 1.2B | AED 14.6B | AED 106.92 | 0.92% down | 169% up | ||
| 50 | ErascaERAS · Health Care | AED 1.2B | AED 17.1B | AED 48.85 | 4.25% down | 403% up | ||
| 51 | Mirum PharmaceuticalsMIRM · Health Care | AED 1.2B | AED 22.1B | AED 338.23 | 0.15% up | 31% up | ||
| 52 | Rhythm PharmaceuticalsRYTM · Health Care | AED 510.8M | AED 30.3B | AED 437.43 | 2.14% up | 13% up | ||
| 53 | Travere TherapeuticsTVTX · Health Care | AED 421.7M | AED 18.1B | AED 188.16 | 0.25% up | 44% up | ||
| 54 | Axsome TherapeuticsAXSM · Health Care | AED 324.3M | AED 25.8B | AED 491.18 | 1.63% down | 7% down | ||
| 55 | Amneal PharmaceuticalsAMRX · Health Care | -AED 260M | AED 28.1B | AED 80.73 | 4.07% up | 83% up | ||
| 56 | VeradermicsMANE · Health Care | -AED 444.5M | AED 19.2B | AED 455.39 | 1.31% down | 233% up | ||
| 57 | Ascendis PharmaASND · Health Care | -AED 663.5M | AED 65.4B | AED 997.08 | 0.11% up | 28% up | ||
| 58 | PTC TherapeuticsPTCT · Health Care | -AED 754.1M | AED 18.6B | AED 222.09 | 0.18% up | 20% down | ||
| 59 | CytokineticsCYTK · Health Care | -AED 2.4B | AED 26.4B | AED 189.68 | 0.01% down | 20% down | ||
| 60 | BridgeBio PharmaBBIO · Health Care | -AED 7.7B | AED 55.8B | AED 286.31 | 1.50% up | 17% up | ||
| 61 | AbbVieABBV · Health Care | -AED 12B | AED 1.87T | AED 1,057.33 | 1.69% down | 26% up |
Sources: share prices and market values from Yahoo Finance; sector, country and category from each company's SEC registration; annual figures from the reports companies file with the SEC.
Market value is share price × shares outstanding, from Yahoo Finance; prices may be delayed 15 minutes or more and the ranking refreshes about every 20 minutes. The list covers companies with shares listed in the US, which includes foreign companies listed through ADRs but not ones listed only abroad. Sector, category and country come from each company's SEC registration. Net assets is from each company's latest annual report filed with the SEC (collected 2026-11-12); a company that reports in another currency is converted to US dollars at the exchange rate of that day, not of the period. Sums are converted from US dollars at today's exchange rate (1 USD = 3.6728 AED).
Questions and answers
Which pharmaceutical companies rank first by net assets?
Pfizer (AED 317.6B), Johnson & Johnson (AED 299.5B) and Sanofi (AED 290.9B) are the top three of the 61 pharmaceutical companies ranked by net assets as of 18 Nov 2026, 17:47 UTC.
How many pharmaceutical companies are in this ranking?
61 are ranked by net assets.
What are these pharmaceutical companies worth together?
The 61 pharmaceutical companies ranked by net assets have a combined market value of AED 18.69T as of 18 Nov 2026, 17:47 UTC.
What does ranking by net assets measure?
Shareholders' equity at the end of the latest fiscal year: what the company owns less what it owes. A negative figure means it owes more than it owns.
Learn how this ranking works
All markets guides →- Altman Z-score: formula, zones and where it fails
The Altman Z-score is a weighted sum of five financial ratios that Edward Altman fitted in 1968 to separate companies that went bankrupt from those that did not. Funkfolio reads above 2.99 as the safe zone, below 1.81 as the distress zone, and between them a grey zone. It does not suit banks or insurers.
- Market cap vs enterprise value: what is the difference?
Market capitalization is the value of a company's shares. Enterprise value is market cap plus debt, minus cash: roughly what it would cost to buy the whole business and settle its borrowings. Two companies with the same $50 billion market cap can have very different enterprise values if one owes $20 billion and the other holds $20 billion in cash.
- How an ETF's size is measured: AUM, NAV and creation units
An ETF's size is usually measured by its assets under management (AUM), the fund's net assets: everything it holds minus what it owes. That equals net asset value per share times shares outstanding. AUM grows when the holdings rise in value and when large institutions create new shares, and shrinks when they redeem them.
Cite this page
Funkfolio, “Largest pharmaceutical companies by net assets”, data as of 18 November 2026. https://funkfolio.com/companies/category/pharmaceuticals?by=net-assets
Underlying data: Yahoo Finance; SEC EDGAR.